Instituto Universitario de Investigación en Neuroquímica
Zentrum/Institut
![Foto de Instituto Universitario de Investigación en Neuroquímica](/img/uploaded/210288F0EBF11B5B400384EE1F7A6332.jpg)
![Foto de Instituto de Investigación Sanitaria Fundación Jiménez Díaz](/img/noimage_org.png)
Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Fundación Jiménez Díaz (8)
2024
-
From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline
British Journal of Pharmacology
-
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype
Frontiers in Cellular and Infection Microbiology, Vol. 14
-
Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?
British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 777-798
-
N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia
Translational Psychiatry, Vol. 14, Núm. 1
-
Oral anticoagulants: A plausible new treatment for Alzheimer's disease?
British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 760-776
2023
-
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia
International Journal of Molecular Sciences, Vol. 24, Núm. 12
-
Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation
British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478
2022
-
A Dual Role for FADD in Human Precursor T-Cell Neoplasms
International Journal of Molecular Sciences, Vol. 23, Núm. 23